454 related articles for article (PubMed ID: 9351981)
21. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
22. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor.
Zhang D; Li JG; Chen C; Liu-Chen LY
Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435
[TBL] [Abstract][Full Text] [Related]
23. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
[TBL] [Abstract][Full Text] [Related]
24. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
25. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
26. A conserved arginine in the distal third intracellular loop of the mu-opioid receptor is required for G protein activation.
Wang HL
J Neurochem; 1999 Mar; 72(3):1307-14. PubMed ID: 10037504
[TBL] [Abstract][Full Text] [Related]
27. Membrane microviscosity modulates mu-opioid receptor conformational transitions and agonist efficacy.
Emmerson PJ; Clark MJ; Medzihradsky F; Remmers AE
J Neurochem; 1999 Jul; 73(1):289-300. PubMed ID: 10386982
[TBL] [Abstract][Full Text] [Related]
28. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
29. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
Yoburn BC; Purohit V; Patel K; Zhang Q
Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
[TBL] [Abstract][Full Text] [Related]
30. Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells.
Alt A; Clark MJ; Woods JH; Traynor JR
Br J Pharmacol; 2002 Jan; 135(1):217-25. PubMed ID: 11786497
[TBL] [Abstract][Full Text] [Related]
31. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
32. Adaptations to chronic agonist exposure of mu-opioid receptor-expressing Chinese hamster ovary cells.
Kato S; Fukuda K; Morikawa H; Shoda T; Mima H; Mori K
Eur J Pharmacol; 1998 Mar; 345(2):221-8. PubMed ID: 9600641
[TBL] [Abstract][Full Text] [Related]
33. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation.
Chakrabarti S; Law PY; Loh HH
J Neurochem; 1998 Jul; 71(1):231-9. PubMed ID: 9648870
[TBL] [Abstract][Full Text] [Related]
34. Agonist-induced signaling and trafficking of the mu-opioid receptor: role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain.
Capeyrou R; Riond J; Corbani M; Lepage JF; Bertin B; Emorine LJ
FEBS Lett; 1997 Sep; 415(2):200-5. PubMed ID: 9350996
[TBL] [Abstract][Full Text] [Related]
35. Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors.
Sim LJ; Liu Q; Childers SR; Selley DE
J Neurochem; 1998 Apr; 70(4):1567-76. PubMed ID: 9523574
[TBL] [Abstract][Full Text] [Related]
36. The absence of a direct correlation between the loss of [D-Ala2, MePhe4,Gly5-ol]Enkephalin inhibition of adenylyl cyclase activity and agonist-induced mu-opioid receptor phosphorylation.
El Kouhen R; Kouhen OM; Law PY; Loh HH
J Biol Chem; 1999 Apr; 274(14):9207-15. PubMed ID: 10092593
[TBL] [Abstract][Full Text] [Related]
37. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
[TBL] [Abstract][Full Text] [Related]
38. Expression of mu-, delta- and kappa-opioid receptors in baculovirus-infected insect cells.
Obermeier H; Wehmeyer A; Schulz R
Eur J Pharmacol; 1996 Dec; 318(1):161-6. PubMed ID: 9007528
[TBL] [Abstract][Full Text] [Related]
39. Alteration of the interaction of mu-opioid receptor and G protein after chronic PL017 treatment in rats.
Tao PL; Lue WM; Lee CR; Chang LR
Chin J Physiol; 1995; 38(3):193-9. PubMed ID: 8846729
[TBL] [Abstract][Full Text] [Related]
40. Internalization and recycling of human mu opioid receptors expressed in Sf9 insect cells.
Chen LE; Gao C; Chen J; Xu XJ; Zhou DH; Chi ZQ
Life Sci; 2003 May; 73(1):115-28. PubMed ID: 12726892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
